The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...
CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...
The plasma fractionation market is projected to reach US$ 40,731.98 million by 2028 from US$ 26,575.83 million in 2021; it is expected to grow at a CAGR of 6.3% during 2021-2028. According to the ...
IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that Grifols’ North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical ...
According to the report, the global plasma fractionation market is expected to generate around $36.8 bn by 2025, at a CAGR of around 7.2% between 2019 and 2025. Worldwide Trends in Plasma ...
ndonesia is set to host its first-ever plasma fractionation plant in Karawang, West Java, which is poised to become the largest such facility in Southeast Asia. This milestone marks a major step ...
Vol. 2, No. 3/4, SPECIAL ISSUE: THE QUALITY OF HEALTH CARE: TRANSACTIONS OF THE 7TH INTERNATIONAL CONGRESS OF THE INTERNATIONAL SOCIETY FOR QUALITY ASSURANCE (1990), pp. 207-212 (6 pages) The use of ...
Blood plasma is a light yellow liquid that makes up about half of a person’s blood. Blood plasma is vital for fighting infection, maintaining correct blood pH levels, helping blood to clot, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results